OccuLogix divests SOLX glaucoma business
This article was originally published in Clinica
Ophthalmic diagnostic device specialist OccuLogix has sold its SOLX glaucoma business unit in order to maximise shareholder value. The company has been struggling with cash flow problems and sold the subsidiary to an unnamed company owned by Doug Adams, the founder and president of SOLX. The purchase fee was not disclosed.